Skip to main content
Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
0.7738
-0.0462 (-5.63%)
At close: Nov 13, 2026, 4:00 PM EST
0.7678
-0.0060 (-0.78%)
After-hours: Nov 13, 2026, 7:18 PM EST

Compass Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-86.36-66.49-49.38-42.49-39.23-82.18
Depreciation & Amortization
1.51.471.751.891.91.62
Loss (Gain) From Sale of Assets
-----0.07-0.04
Asset Writedown & Restructuring Costs
-----50.62
Loss (Gain) From Sale of Investments
-1.52-1.67-1.65-3.23-0.8-
Stock-Based Compensation
15.738.378.566.125.334.03
Other Operating Activities
-----0.04
Change in Accounts Payable
3.22-0.66-1.840.712.52-0.19
Change in Other Net Operating Assets
5.859.84-2.3-3.62-3.786.44
Operating Cash Flow
-61.58-49.14-44.86-40.62-34.13-19.67
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.36-0.03-0.04-0.03-0.21-1.89
Sale of Property, Plant & Equipment
----0.180.12
Investment in Securities
52.77-93.2846.8227-151.16-
Investing Cash Flow
52.41-93.3146.7726.97-151.2-1.77

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
------9.38
Net Debt Issued (Repaid)
------9.38
Issuance of Common Stock
5.13139.2718.113.1976.25128.27
Repurchase of Common Stock
-0.7-1.03-0.23-0.16--
Other Financing Activities
--8.64-0.54-0.09-0.5-0.28
Financing Cash Flow
4.43129.6117.342.9475.76118.61

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Miscellaneous Cash Flow Adjustments
--0.57---
Net Cash Flow
-4.74-12.8419.82-10.72-109.5797.18

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-61.94-49.17-44.9-40.65-34.34-21.55
Free Cash Flow Growth
------
Free Cash Flow Margin
---5282.23%---
Free Cash Flow Per Share
-0.33-0.31-0.33-0.32-0.33-0.34
Levered Free Cash Flow
-32.23-26.16-27.8-25.2-19.17-8.46
Unlevered Free Cash Flow
-32.23-26.16-27.8-25.2-19.17-8.23

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
-----0.37
Change in Working Capital
9.079.18-4.14-2.91-1.266.25
SEC Filings: 10-K · 10-Q